MedTrace Logo

Obstructive Sleep Apnea Treatment and Insulin Sensitivity in Pregnancy

NCT04013399 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-07-27

No results posted yet for this study

Summary

This study will evaluate the effect of treatment of obstructive sleep apnea on insulin sensitivity in pregnant women. Women in their third trimester of pregnancy will be randomized to receive treatment or no treatment for one month.

Conditions

Interventions

DEVICE

Continuous Positive Airway Pressure

The device is an auto-adjusting pressure device with an integrated humidifier. Pressure is adjusted based on airway resistance.

Sponsors & Collaborators

  • Washington University School of Medicine

    collaborator OTHER

  • Barnes-Jewish Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2022-09-30
Completion
2023-03-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04013399 on ClinicalTrials.gov